Mar 24, 2025 8:30am EDT Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025
Mar 13, 2025 7:30am EDT Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults
Mar 13, 2025 CEO Dr. Adam Mendelsohn and CBO Don Dwyer participated in a Vivani-hosted investor conference call to discuss recent progress in the LIBERATE-1 clinical trial
Sep 25, 2024 CEO Dr. Adam Mendelsohn presented at the Emerging Growth Conference on September 25, 2024.
Sep 24, 2024 CEO Dr. Adam Mendelsohn joined Daniel Levine on the September 24, 2024 installment of The Bio Report podcast to discuss Vivani Medical’s implantable drug delivery technology, how it works, and why its lead indication is a GLP-1 implant for weight loss and diabetes.